Latest Production News

Sunshine Metals has reported outstanding near-surface gold and silver intercepts from its ongoing drilling at the Liontown deposit, signalling a potential upgrade to its resource and mining plans.

GBM Resources has reported a successful Stage 1 drilling campaign at its Twin Hills gold project in Queensland, revealing significant high-grade gold mineralisation beyond existing resources. The company also advanced its portfolio strategy by divesting non-core assets and securing a substantial capital raise.

Minerals 260 Limited has significantly expanded its Bullabulling Gold Project resource to 4.5 million ounces, nearly doubling its previous estimate, while advancing key development milestones ahead of a mid-2026 Pre-Feasibility Study completion.

Bioxyne Limited has reported a record $17.2 million in quarterly revenue, driven by strong growth in its cannabis and psychedelics segments, alongside strategic international expansions including a Frankfurt dual listing and new manufacturing agreements.

Dubber Corporation Limited has signed a significant five-year contract with a major North American communications provider, while trimming costs and targeting operating cashflow breakeven in FY26.

American Tungsten & Antimony Ltd has acquired the Dutch Mountain Tungsten Project and its fully permitted processing facility in Utah, positioning itself to accelerate tungsten production in the US by bypassing lengthy federal permitting.

Greatland Resources capped off 2025 with robust gold and copper production at Telfer, generating $406 million in operating cash flow, while its Havieron feasibility study confirmed a world-class, low-cost gold-copper mine with a $4.2 billion pre-tax NPV.

Develop Global Limited reports strong December quarter progress with Woodlawn mine commissioning on track, a major contract win, and a significant value uplift at Sulphur Springs ahead of a mid-2026 investment decision.

LTR Pharma has marked a key milestone with over 1,000 SPONTAN prescriptions under Australia’s Special Access Scheme and is advancing clinical trials and US market preparations for its erectile dysfunction treatments.

Ampol Limited reports a robust fourth quarter Lytton Refiner Margin of US$15.14 per barrel, underpinning a strong preliminary FY25 earnings update with an expected EBIT of approximately $945 million.

Control Bionics has raised $3.8 million to fuel growth, forged a key distribution deal with Tobii, and integrated with Apple’s BCI protocol, while advancing its NeuroStrip and NeuroBounce platforms.

Develop Global Limited reported a positive operating cash flow of AUD 18.8 million for the December 2025 quarter, maintaining robust liquidity despite significant investing and financing cash outflows.